Ocular Therapeutix Inc (NAS:OCUL)
$ 9.89 -0.17 (-1.69%) Market Cap: 1.55 Bil Enterprise Value: 1.23 Bil PE Ratio: 0 PB Ratio: 4.40 GF Score: 65/100

Q1 2022 Ocular Therapeutix Inc Earnings Call Transcript

May 09, 2022 / 08:30PM GMT
Release Date Price: $3.26 (-6.05%)
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ocular Therapeutix First Quarter 2022 Earnings Conference Call. (Operator Instructions) It is now my pleasure to introduce Donald Notman, Chief Financial Officer of Ocular Therapeutix. Please go ahead, sir.

Donald Notman
Ocular Therapeutix, Inc. - CFO

Thank you, operator. Good afternoon, everyone, and thank you for joining us on our first quarter 2022 financial results and business update conference call. This afternoon, after the close, we issued a press release providing an update on the company's product development programs and details of the company's financial results for the quarter ended March 31, 2022.

The press release can be accessed on the investors portion of our website at investors.ocutx.com. Leading the call today will be Antony Mattessich, our President and Chief Executive Officer, who will provide an update on the commercial progress of DEXTENZA and a summary of our corporate developments. Also speaking on the call today will be Dr. Michael Goldstein,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot